IN2014MN02582A - - Google Patents

Info

Publication number
IN2014MN02582A
IN2014MN02582A IN2582MUN2014A IN2014MN02582A IN 2014MN02582 A IN2014MN02582 A IN 2014MN02582A IN 2582MUN2014 A IN2582MUN2014 A IN 2582MUN2014A IN 2014MN02582 A IN2014MN02582 A IN 2014MN02582A
Authority
IN
India
Prior art keywords
compound
formula
present
discloses
preparing
Prior art date
Application number
Other languages
English (en)
Inventor
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Srinivas Laxminarayan Pathi
Ravikumar Puppala
Manish Gangrade
Shashirekha Kanathala
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN2582MUN2014 priority Critical patent/IN2014MN02582A/en
Publication of IN2014MN02582A publication Critical patent/IN2014MN02582A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/022—Boron compounds without C-boron linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN2582MUN2014 2006-11-13 2007-11-13 IN2014MN02582A (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2582MUN2014 IN2014MN02582A (ru) 2006-11-13 2007-11-13

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1879MU2006 2006-11-13
PCT/GB2007/004320 WO2008059223A2 (en) 2006-11-13 2007-11-13 Process for the synthesis of moxifloxacin hydrochloride
IN2582MUN2014 IN2014MN02582A (ru) 2006-11-13 2007-11-13

Publications (1)

Publication Number Publication Date
IN2014MN02582A true IN2014MN02582A (ru) 2015-09-11

Family

ID=38947366

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2582MUN2014 IN2014MN02582A (ru) 2006-11-13 2007-11-13

Country Status (10)

Country Link
US (1) US8198451B2 (ru)
EP (2) EP2474547A3 (ru)
JP (2) JP2010509305A (ru)
KR (2) KR101539561B1 (ru)
AU (1) AU2007320997B2 (ru)
CA (1) CA2669427A1 (ru)
IN (1) IN2014MN02582A (ru)
NZ (1) NZ576929A (ru)
WO (1) WO2008059223A2 (ru)
ZA (1) ZA200903889B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101539561B1 (ko) 2006-11-13 2015-07-27 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법
CN101817820B (zh) * 2009-07-30 2011-10-05 重庆博腾制药科技股份有限公司 一种盐酸莫西沙星的合成方法
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
CN102309458B (zh) * 2010-07-09 2016-02-03 北京圣医耀科技发展有限责任公司 海藻酸钠交联莫西沙星缓释微球、其制备方法和用途以及含有所述微球的血管靶向栓塞剂
CN102617622B (zh) * 2011-01-31 2016-06-15 深圳信立泰药业股份有限公司 一种制备莫西沙星或其可药用盐及其中间体的方法
CN102276603B (zh) * 2011-07-14 2012-10-24 福建省福抗药业股份有限公司 一种盐酸莫西沙星的清洁制备方法
ITTO20110705A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Procedimento di preparazione della moxifloxacina cloridrato e relativi intermedi
CN102659761B (zh) * 2012-04-27 2017-10-10 常州市亚邦医药研究所有限公司 盐酸贝西沙星的制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
US9388178B2 (en) 2012-12-04 2016-07-12 Mankind Research Centre Process for the preparation of moxifloxacin hydrochloride
CN103102341A (zh) * 2012-12-14 2013-05-15 浙江普洛康裕制药有限公司 一种巴洛沙星二水合物的制备方法
CN103012452B (zh) * 2012-12-25 2015-12-02 浙江新和成股份有限公司 一种莫西沙星及其盐酸盐的制备方法
CN104098561B (zh) * 2013-04-10 2016-01-20 山东省生物医药科学院 一种适合工业化生产的制备高光学纯度盐酸莫西沙星的方法
CN104031043B (zh) * 2014-05-28 2016-03-16 成都克莱蒙医药科技有限公司 一种盐酸莫西沙星合成方法
CN104860944A (zh) * 2015-06-09 2015-08-26 内蒙古东北六药集团有限公司 盐酸莫西沙星的生产方法
CN105237535A (zh) * 2015-11-15 2016-01-13 青岛麦瑞特医药技术有限公司 一种制备盐酸莫西沙星的方法
CN105669671A (zh) * 2016-03-10 2016-06-15 陈红 一种盐酸莫西沙星的制备方法
CN110143959B (zh) * 2019-05-10 2022-04-26 广西两面针亿康药业股份有限公司 一种盐酸莫西沙星的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46451B (sh) * 1987-04-08 1993-10-20 Chinoin Gyogyszer Es Vegyeszeti Ter Mekek Gyara Rt. Postupak za dobivanje mešovitih anhidrida hinolin-karboksilne i borne kiseline
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
JPH0778065B2 (ja) * 1990-07-06 1995-08-23 杏林製薬株式会社 （６，７―置換―８―アルコキシ―１―シクロプロピル―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸―ｏ▲上３▼，ｏ▲上４▼）ビス（アシルオキシ―ｏ）ホウ素化合物及びその塩並びにその製造方法
TW209865B (ru) 1992-01-10 1993-07-21 Bayer Ag
ES2077490B1 (es) 1992-11-18 1996-10-16 Marga Investigacion Esteres trimetilsililicos y solvatos de quelatos de acidos quinolin-3-carboxilicos. preparacion y aplicacion al proceso de quinolonas.
DE4342186A1 (de) 1993-12-10 1995-06-14 Bayer Ag Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19821039A1 (de) * 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
US6174878B1 (en) * 1999-08-31 2001-01-16 Alcon Laboratories, Inc. Topical use of kappa opioid agonists to treat otic pain
CN1184221C (zh) 2001-08-08 2005-01-12 中国医学科学院医药生物技术研究所 有7－(7－氨甲基－5－氮杂螺[2,4]庚烷)取代基的新喹啉羧酸衍生物及其制备方法
DE602004022646D1 (de) * 2003-04-09 2009-10-01 Reddys Lab Ltd Dr Kristalline form iii von wasserfreiem moxifloxacin-hydrochlorid und ein verfahren zu seiner herstellung
EP1651630A1 (en) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
WO2005054240A1 (en) * 2003-11-20 2005-06-16 Chemi Spa Polymorphs of 1-cyclopropyl-7-([s,s]-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7320006B2 (en) * 2004-11-12 2008-01-15 Computer Sciences Corporation Hierarchical database management
WO2006134491A2 (en) 2005-06-14 2006-12-21 Aurobindo Pharma Limited New crystalline form of moxifloxacin hydrochloride and process for its preparation
WO2007010555A2 (en) * 2005-07-15 2007-01-25 Msn Laboratories Limited Novel crystalline forms of moxifloxacin hydrochloride and process for preparation thereof
ES2284380B1 (es) * 2006-03-10 2008-11-01 Quimica Sintetica S.A. Procedimiento para la preparacion de moxifloxacino y moxifloxacino clorhidrato.
KR101539561B1 (ko) 2006-11-13 2015-07-27 씨아이피엘에이 엘티디. 목시플록사신 염산염의 합성방법

Also Published As

Publication number Publication date
KR20150048920A (ko) 2015-05-07
CA2669427A1 (en) 2008-05-22
KR20090090337A (ko) 2009-08-25
NZ576929A (en) 2012-07-27
WO2008059223A2 (en) 2008-05-22
EP2089388B1 (en) 2014-01-29
JP5774732B2 (ja) 2015-09-09
JP2010509305A (ja) 2010-03-25
KR101539561B1 (ko) 2015-07-27
EP2474547A2 (en) 2012-07-11
ZA200903889B (en) 2010-03-31
WO2008059223A3 (en) 2008-07-31
EP2089388A2 (en) 2009-08-19
JP2014122223A (ja) 2014-07-03
AU2007320997A1 (en) 2008-05-22
AU2007320997B2 (en) 2012-11-08
US8198451B2 (en) 2012-06-12
EP2474547A3 (en) 2012-07-25
US20100152229A1 (en) 2010-06-17

Similar Documents

Publication Publication Date Title
IN2014MN02582A (ru)
TW200706636A (en) Compounds for organic electronic devices
TW200613515A (en) Compounds for organic electronic devices
TN2011000247A1 (en) Organic compounds
EA201170524A1 (ru) Урацилсодержащие соединения и гербициды, включающие такие соединения
WO2008101187A3 (en) Pro-drugs of peripheral phenolic opioid antagonists
ATE504554T1 (de) Verfahren zur substitution von indenofluorenen
WO2011038185A3 (en) Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
EG25480A (en) Method for preparation of optionally 2-substituted1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
HK1135096A1 (en) Process for preparing 6-phenoxypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivative
BRPI0513712A (pt) método para a preparação de derivado de d-eritro-2,2-difluoro-2-desóxi-1-oxorribose
WO2009066735A1 (ja) ２－アザアダマンタン類の製造方法
MX2009004991A (es) Derivados de monoacetato de ciclopenteno-diol.
TW200619213A (en) A process for the preparation of organic compounds
WO2009001203A3 (en) An improved process for the preparation of aprepitant
WO2010120058A3 (ko) 생체 분자 표지를 위한 신규 시아닌 화합물 및 그 제조방법
WO2006000390A3 (de) Verbindungen für organische elektronische vorrichtungen
UA99455C2 (ru) Эпоксидное соединение, способ его получения и способ получения соединения оксазола
DE602006014001D1 (de) Herstellung von 2-aminothiazol-5-carbonsäurederivaten
NO20065157L (no) Biotransformasjon av colchicinoidforbindelser
WO2008132966A1 (ja) 化合物、酸発生剤、レジスト組成物およびレジストパターン形成方法
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2011028034A3 (en) Dopant diffusion solution, paste composition for electrode, and method of forming doping area
IL194337A0 (en) Method for preparing lysobactin derivatives
BRPI0509360A (pt) processo para preparação de derivados de diazina